Division of Infectious Diseases, Nitte University Centre for Science Education and Research, Nitte (Deemed to be University), Deralakatte, Mangaluru, 575018, India.
Department of Microbiology, The Madras Medical Mission, 4-A, Dr, Mogappair, Chennai, Tamil Nadu, 600037, India.
Virus Res. 2021 Jan 2;291:198222. doi: 10.1016/j.virusres.2020.198222. Epub 2020 Nov 6.
The envelope glycoprotein (E) is the smallest structural component of SARS-CoVs; plays an essential role in the viral replication starting from envelope formation to assembly. The in silico analysis of 2086 whole genome sequences from India performed in this study provides the first observation on the extensive deletion of amino acid residues in the C-terminal region of the envelope glycoprotein in 34 Indian SARS-CoV-2 genomes. These amino acid deletions map to the homopentameric interface and PDZ binding motif (PBM) present in the C-terminal region of E protein as well as immediately after the reverse primer binding region as per Charité protocol in 26 of these genomes, hence, their detection through RT-qPCR may not be hampered and therefore E gene-based RT-qPCR would still detect these isolates. Eight genomes from the State of Odisha had deletion even in the primer binding site. It is possible that the deletions in the C-terminal region of E protein of these genomes are a result of adapting to a newer geographical area and host. The information on the clinical status was available only for 9 out of 34 cases and these were asymptomatic. However, further studies are indispensable to understand the functional consequences of amino acid deletion in the C terminal region of SARS-CoV-2 envelope protein in the viral pathogenesis and host adaptation.
包膜糖蛋白(E)是 SARS-CoV 中最小的结构成分;在从包膜形成到组装的病毒复制过程中起着至关重要的作用。本研究对印度 2086 个全基因组序列进行了计算机分析,首次观察到 34 个印度 SARS-CoV-2 基因组中包膜糖蛋白 C 末端区域的氨基酸残基广泛缺失。这些氨基酸缺失位于 E 蛋白 C 末端的同源五聚体界面和 PDZ 结合基序(PBM)以及根据 Charité 方案在 26 个基因组中逆转录引物结合区域之后,因此,通过 RT-qPCR 检测不会受到阻碍,因此基于 E 基因的 RT-qPCR 仍将检测到这些分离株。来自奥里萨邦的 8 个基因组甚至在引物结合位点都有缺失。这些基因组中 E 蛋白 C 末端的缺失可能是为了适应新的地理区域和宿主。关于临床状况的信息仅可用于 34 例中的 9 例,且这些都是无症状的。然而,进一步的研究对于理解 SARS-CoV-2 包膜蛋白 C 末端氨基酸缺失在病毒发病机制和宿主适应中的功能后果是必不可少的。